Anyone arriving back in the UK from the southern European country after that time will have to self-isolate for 10 days following its removal from the green travel list.
Covid latest: Important update for anyone who s had the Pfizer vaccine as Delta variant spikes cambridge-news.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cambridge-news.co.uk Daily Mail and Mail on Sunday newspapers.
Pfizer vaccine recipients have lower antibodies targeting Indian variant – study
Pfizer vaccine recipients have lower antibodies targeting Indian variant – study (Nick Potts/PA)
People who have had the Pfizer/BioNTech vaccine have lower antibody levels targeting the coronavirus variant first discovered in India than those against previously circulating variants in the UK, new data suggests.
The research also suggests the levels of these antibodies are lower with increasing age and that levels decline over time.
Researchers say this provides additional evidence in support of plans to deliver a vaccination boost to vulnerable people in the autumn.
The new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre also supports current plans to reduce the dose gap between vaccines.
The data from the Francis Crick Institute and the National Institute for Health Research UCLH Biomedical Research Centre also supports current plans to reduce the dose gap between jabs.
Pfizer vaccine recipients have lower antibodies targeting the Delta variant. Credit: PA
People who have received the Pfizer vaccine have lower antibody levels that target the Delta variant, first discovered in India, than those that targeted previously circulating variants in the UK, new data suggests.
The study found that after just one dose of the Pfizer jab, people are less likely to develop antibody levels against the Delta variant, as high as those seen against the previously dominant Alpha variant, which was first discovered in Kent.
The study, from the Francis Crick Institute and the National Institute for Health Research, suggests the level of such antibodies are lower with older age and that the levels decline over time.